Dr. Utpal Tatu obtained his Ph.D. from the Indian Institute of Science and did his post-doctoral research at Yale School of Medicine, New Haven, Connecticut. He is currently a Professor in the Department of Biochemistry at the Indian Institute of Science. His research aims to develop cheaper and more effective medicines for neglected diseases such as malaria, giardiasis, amoebiasis, trypanosomoses, and candidiasis. Prof. Tatu has made extensive use of bio-analytical tools including mass spectrometry in his research for both proteomic and metabolomic applications. He serves as an expert panel member on the United States Pharmacopeia Therapeutic Protein Panel. In addition to carrying out educational workshops for various institutions he has offered thematic workshops together with United States Pharmacopeia on bio-analytical methods for various biopharma companies. Prof. Tatu’s lab has established a successful academia-industry interaction. In addition to analyzing over two thousand challenging samples for various biopharmaceutical and pharmaceutical industries his lab has collaborated with various national and international organizations for drug development projects and biosimilar characterization. Prof. Tatu holds international patents and is a recipient of several national and international awards including the Birla science prize, Bioscience career development award from DBT, and Ranbaxy Research Award to mention a few. He is an elected fellow of the Indian Academy of Sciences and serves on the research advisory boards of several biotech companies in India and abroad. He is closely involved in advising Biopharma companies about Bio-therapeutic protein characterization. Prof. Tatu is an editorial board member of the Parasitology Journal published by the Cambridge Press. He serves as the Vice President of Proteomics Society of India and was formerly Vice President of the Indian Society for Mass Spectrometry.